Tricuspid regurgitation classification

Jump to navigation Jump to search

Tricuspid Regurgitation Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Tricuspid Regurgitation from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Stages

History and Symptoms

Physical Examination

Laboratory Findings

Echocardiography

Chest X Ray

Electrocardiogram

Cardiac Stress Test

Cardiac MRI

Cardiac Catheterization

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical therapy

Surgery

Primary Prevention

Secondary Prevention

Case Studies

Case #1

Tricuspid regurgitation classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Tricuspid regurgitation classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA onTricuspid regurgitation classification

CDC on Tricuspid regurgitation classification

Tricuspid regurgitation classification in the news

Blogs on Tricuspid regurgitation classification

Directions to Hospitals Treating Tricuspid regurgitation

Risk calculators and risk factors for Tricuspid regurgitation classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Rim Halaby, M.D. [2] Fatimo Biobaku M.B.B.S [3]

Overview

Tricuspid regurgitation (TR) can be broadly classified as primary or secondary. Primary (or organic) TR results from an organic lesion of the tricuspid valve itself, whereas secondary (or functional) TR is caused by left heart failure or pulmonary hypertension without an intrinsic abnormality of the tricuspid valve.

Classification

2014 AHA/ACC Guidelines for Valvular Heart Diseases[1][2][3][4][5][6]

Abbreviations: CW: continuous wave; ICD: implantable cardioverter-defibrillator; IE: infective endocarditis; IVC: inferior vena cava; RA: right atrium; RV: right ventricle; TR: tricuspid regurgitation

Stage Definition Valve anatomy Valve hemodynamics Hemodynamic consequences Symptoms of TR, left heart failure, or pulmonary vascular disease
A At risk of TR Primary

Secondary

  • No abnormal findings
  • Beginning of annular dilation
Absent or trace TR Absent Absent
B Progressive TR Primary
  • Progressive leaflet deterioration/destruction
  • Moderate-to-severe prolapse and limited chordal rupture

Secondary

  • Beginning of annular dilation
  • Moderate leaflet tethering
Mild TR
  • Central jet area <5.0 cm2
  • Undefined width of vena contracta
  • Soft and parabolic CW jet density and contour
  • Systolic dominance of hepatic vein flow

Moderate TR

  • Central jet area 5–10 cm2
  • Undefined width of vena contracta width but <0.70 cm
  • Dense, variable CW jet density and contour
  • Systolic blunting of hepatic vein flow
Mild TR
  • Normal size of RV/RA/IVC

Moderate TR

  • Absence of RV enlargement
  • Absent or mild RA enlargement
  • Absent or mild IVC enlargement with normal respirophasic variation
  • Normal RA pressure
Absent
C Asymptomatic severe TR Primary
  • Flail or grossly distorted leaflets

Secondary

  • Severe annular dilation (>40 mm or 21 mm/m2)
  • Marked leaflet tethering
* Central jet area >10.0 cm

2* Vena contracta width >0.7 cm

* Dilated RV/RA/IVC and decreased IVC respirophasic variation
  • Increased RA pressure with “c-V” wave
  • Possible diastolic interventricular septal flattening
Absent
D Symptomatic severe TR Primary
  • Flail or grossly distorted leaflets

Secondary

  • Severe annular dilation (>40 mm or 21 mm/m2)
  • Marked leaflet tethering
* Central jet area >10.0 cm2
  • Vena contracta width >0.7 cm
  • Dense, triangular CW jet density and contour with early peak
  • Systolic reversal in hepatic vein flow
* Dilated RV/RA/IVC and decreased IVC respirophasic variation
  • Increased RA pressure with “c-V” wave
  • Possible diastolic interventricular septal flattening
Presence of symptoms (fatigue, dyspnea, anorexia, edema, abdominal distention, palpitations)

References

  1. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Guyton RA; et al. (2014). "2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines". Circulation. doi:10.1161/CIR.0000000000000029. PMID 24589852.
  2. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Fleisher LA, Jneid H, Mack MJ, McLeod CJ, O'Gara PT, Rigolin VH, Sundt TM, Thompson A (June 2017). "2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines". Circulation. 135 (25): e1159–e1195. doi:10.1161/CIR.0000000000000503. PMID 28298458.
  3. Sagie A, Schwammenthal E, Padial LR, Vazquez de Prada JA, Weyman AE, Levine RA (1994). "Determinants of functional tricuspid regurgitation in incomplete tricuspid valve closure: Doppler color flow study of 109 patients". J Am Coll Cardiol. 24 (2): 446–53. doi:10.1016/0735-1097(94)90302-6. PMID 8034882.
  4. Spinner EM, Lerakis S, Higginson J, Pernetz M, Howell S, Veledar E; et al. (2012). "Correlates of tricuspid regurgitation as determined by 3D echocardiography: pulmonary arterial pressure, ventricle geometry, annular dilatation, and papillary muscle displacement". Circ Cardiovasc Imaging. 5 (1): 43–50. doi:10.1161/CIRCIMAGING.111.965707. PMID 22109981.
  5. Tornos Mas P, Rodríguez-Palomares JF, Antunes MJ (2015). "Secondary tricuspid valve regurgitation: a forgotten entity". Heart. 101 (22): 1840–8. doi:10.1136/heartjnl-2014-307252. PMC 4680164. PMID 26503944.
  6. Irwin RB, Luckie M, Khattar RS (2010). "Tricuspid regurgitation: contemporary management of a neglected valvular lesion". Postgrad Med J. 86 (1021): 648–55. doi:10.1136/pgmj.2009.090886. PMID 20956397.

Template:WH Template:WS